Genfit S.A. (GNFTF)
OTCMKTS · Delayed Price · Currency is USD
8.03
0.00 (0.00%)
At close: Feb 11, 2026
Genfit Market Cap
Genfit has a market cap or net worth of $397.04 million as of February 12, 2026. Its market cap has increased by 113.79% in one year.
Market Cap
397.04M
Enterprise Value
434.30M
Revenue
52.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.03
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 192.64M to 397.04M, an increase of 106.11%. That is a compound annual growth rate of 3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 397.04M | 28.98% |
| Dec 31, 2025 | 307.82M | 68.67% |
| Dec 31, 2024 | 182.50M | -6.18% |
| Dec 29, 2023 | 194.52M | -7.62% |
| Dec 30, 2022 | 210.57M | -13.73% |
| Dec 31, 2021 | 244.08M | 28.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |